H.C. Wainwright Maintains Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Maintains Target Price $19

Futu NewsJan 13 21:35 · Ratings

TD Cowen Maintains Arcutis Biotherapeutics(ARQT.US) With Buy Rating, Maintains Target Price $20

Futu NewsJan 13 21:35 · Ratings

A Quick Look at Today's Ratings for Arcutis Biotherapeutics(ARQT.US), With a Forecast Between $19 to $20

Futu NewsJan 13 21:00 · Ratings

TD Cowen Remains a Buy on Arcutis Biotherapeutics (ARQT)

TipRanksJan 13 20:45 · Ratings

Why Sage Therapeutics Shares Are Trading Higher By Over 34%; Here Are 20 Stocks Moving Premarket

BenzingaJan 13 18:45

Express News | Arcutis Biotherapeutics Inc : Needham Raises Target Price to $20 From $18

BreakingsJan 13 18:10